What are the main laws governing healthcare advertising in India?

The six rule sets at a glance

What this means for a hospital or clinic campaign

Most compliant healthcare campaigns follow a few habits: describe services, facilities, accreditation and doctors factually; avoid words like "best", "No. 1" or "guaranteed" unless independently verifiable; never use patient testimonials or before-and-after images in promotion; keep drug and treatment claims within what the law allows; and collect clear consent before using phone numbers or health details for marketing. Platform rules sit on top: Google and Meta both restrict health targeting and certain treatment claims.

Platform rules sit on top of the law

Google and Meta apply their own healthcare policies in addition to Indian law. Google restricts ads for prescription medicines and certain treatments and may require certification for some healthcare advertisers. Meta does not allow ads that imply a viewer has a health condition, limits targeting based on health, and restricts before-and-after imagery. An ad can be approved by a platform and still breach Indian law, or comply with the law and still be rejected by a platform, so campaigns need to pass both checks.

Common mistakes that cause trouble

• Outcome promises: phrases like "permanent cure", "100% success" or "guaranteed results" invite complaints under the Drugs and Magic Remedies Act, ASCI and consumer law.
• Superiority claims: "best hospital in the city" or "No. 1 IVF centre" need independent verification under the NMC guidelines and ASCI's code.
• Testimonials and before-after images: ruled out for doctors and hospitals in promotion under the NMC's 2026 guidelines.
• Discounts as inducements: free procedures and referral rewards are restricted for medical practitioners.
• Using patient data without consent: uploading patient phone lists for retargeting or messaging without clear consent conflicts with the DPDP Act.
• Undisclosed endorsements: paid creator posts without a clear #ad or #collaboration label breach ASCI's influencer guidelines.

A simple pre-launch checklist

1. Is every claim factual and supportable with evidence you can show?
2. Does the ad avoid cure claims for listed diseases and conditions?
3. Are there no testimonials, before-after images, superiority claims or inducements?
4. Is the doctor named with qualifications and registration where the content is in a doctor's name?
5. Does the landing page match the ad and carry the same standard of accuracy?
6. Was consent collected for any patient data used in targeting or follow-up?
7. Have Google's or Meta's healthcare policies been checked for this treatment?

Running every campaign through a short checklist like this, with a named reviewer, prevents most problems before they reach a regulator or platform. ICG builds this review step into every healthcare campaign it runs; see our healthcare marketing service.

Who enforces these rules

State Medical Councils act on NMC guideline breaches by doctors, with penalties from a warning to suspension of registration. Drug controllers enforce the Drugs and Magic Remedies Act and Drugs and Cosmetics Act. ASCI handles complaints about advertising content, the CCPA can act on misleading ads, and the Data Protection Board enforces DPDP. This page explains marketing practice, not legal advice; check borderline claims with your legal or compliance team.

How the rules differ for pharma companies

Pharma brands work under a different emphasis. Prescription medicines can be promoted only to healthcare professionals, so consumer campaigns focus on disease awareness without naming the drug. The Uniform Code for Pharmaceutical Marketing Practices governs promotion to doctors, including gifts, hospitality, sponsorship and the accuracy of medical claims, and content must stay consistent with the approved label. Over-the-counter products and nutraceuticals can advertise to consumers, but still within the Drugs and Magic Remedies Act, FSSAI rules for supplements, and ASCI's code.

Detailed answers